EGFR and depressive disorder: The abnormal expression of ERBB (epidermal growth factor receptor, EGFR, epidermal growth factor receptor) signaling pathway can lead to oligodendrocytes (OL) abnormalities, which results in dopaminergic dysfunction, and it may be associated with depression [41]–[42].